Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo initially sought $3.1 billion and after more than half of its trade secrets were dismissed, reduced the request to ...

Thrivent Financial for Lutherans increased its holdings in shares of Masimo by 42.1% in the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Masimo Corp. ( (MASI) ) has released its Q3 earnings. Here is a breakdown of the information Masimo Corp. presented to its investors. Masimo ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on MASI: Masimo CorpShs NewsMORE ...

The jury voted 6 to 1 in favor of Apple on these claims. Furthermore, the judge ruled against Masimo's claims regarding Apple's hiring practices, noting that employees can move between companies.

For the current quarter ending in December, Masimo expects its per-share earnings to range from $1.35 to $1.50. The company said it expects revenue in the range of $581 million to $611 million for ...

Full-Year 2024 Non-GAAP EPS Guidance: $3.95 to $4.10. Unrecognized Contract Revenues: $1.65 billion as of the end of Q3. Masimo Corp (NASDAQ:MASI) reported healthcare revenues of $343 million for ...

Return on Equity (ROE): Masimo's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.17%, the company may face hurdles in generating ...